Ajanta Pharma Ltd. (AJANTPHARM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 178818,
    "name": "Ajanta Pharma",
    "stock_name": "Ajanta Pharma",
    "full_name": "Ajanta Pharma Ltd.",
    "name_url": "stocks-analysis/ajanta-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "3,407.00",
    "chg": -30.25,
    "chgp": "-0.88%",
    "dir": -1,
    "prev_price": "3,437.25",
    "mcapval": "42,383.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532331,
    "symbol": "AJANTPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE031B01049",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "1.28 lacs",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/ajanta-pharma-178818-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Ajanta Pharma Ltd slips for fifth straight session",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-08-24 14:16:35",
        "description": "Ajanta Pharma Ltd slips for fifth straight session  Business Standard..."
      },
      {
        "title": "Ajanta Pharma among 5 midcap stocks to hit 52-week highs & surge up to 18% in a month",
        "link": "https://news.google.com/rss/articles/CBMi-wFBVV95cUxQbmRQUmV6eEdMUnRzWUM5cTFRTTlBR1Z5WG1nUDZYYzVXbHNpS1VxZWpCWWJDMGtWc1hIQ0t3OThPTW9rcnRZSTdFY0xRUnZoV2FPZTZqTXdXNzh4QjE0REVYQjgtM0Y3MVI0U2lKbTIwcFowek5DX1JEMjF5M2ZJNThZY0NSbnZEMUJ2WEVkR0FRUTNFQmhLd2tHQkg2SHE5c04wSWJUVzZ0cmdibTJ1d21mUzJ0WmVZVExNWjNMWC10UFl0alpBQktCUWhpOVhQUFpfd3hkUE1YbkNia2ZPUE9lQlpibm4wdnkzNHJ1TjNVOVFiNnFqR3RJSQ?oc=5",
        "imagepath": "",
        "date": "2026-08-18 17:23:48",
        "description": "Ajanta Pharma among 5 midcap stocks to hit 52-week highs & surge up to 18% in a month  The Economic Times..."
      },
      {
        "title": "Ajanta Pharma Ltd soars 0.37%, rises for fifth straight session",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-08-04 13:17:05",
        "description": "Ajanta Pharma Ltd soars 0.37%, rises for fifth straight session  Business Standard..."
      },
      {
        "title": "Ajanta Pharma Q1 result: PAT rises 31% to 334 cr on strong India, US sales",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-30 15:30:21",
        "description": "Ajanta Pharma Q1 result: PAT rises 31% to 334 cr on strong India, US sales  Business Standard..."
      },
      {
        "title": "Ajanta Pharma Q1 results: PAT rises 31% to 334 cr",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-30 15:06:47",
        "description": "Ajanta Pharma Q1 results: PAT rises 31% to 334 cr  BusinessLine..."
      }
    ],
    "total": 5,
    "sid": "178818",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/ajanta-pharma-178818"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
      "datetime": "06-Oct-2026",
      "details": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on October 06 2026 for Aayush Agrawal trustee Aayush Agrawal Trust",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "01-Oct-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for CTL Trusteeship Ltd",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Sustainability Report For FY 2026",
      "datetime": "30-Sep-2026",
      "details": "Pls find enclosed herewith Sustainability Report for FY 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Ajanta Pharma Ltd. has declared <strong>1600%</strong> dividend, ex-date: 05 Aug 26",
          "dt": "2026-08-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Ajanta Pharma Ltd. has announced <strong>2:5</strong> stock split, ex-date: 20 Mar 15",
          "dt": "2015-03-20",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Ajanta Pharma Ltd. has announced <strong>1:2</strong> bonus issue, ex-date: 22 Jun 22",
          "dt": "2022-06-22",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views